D-Wave Quantum vs. IonQ: Which Quantum Computing Stock Is a Better Buy in 2026?

IonQ posted 2025 revenue of $130 million, up 202% year over year, and Q1 2026 revenue of $64.7 million, up 755%, while maintaining zero debt and a 15.5x current ratio. D-Wave also grew quickly, with 2025 revenue rising 179% to $24.6 million and a 42.4x current ratio, but it remains smaller, more loss-making, and trades at a far richer 806.7x P/S versus IonQ's 107.5x. The article’s conclusion favors IonQ on growth, scale, and valuation, though both companies remain highly speculative and unprofitable.

Analysis

The market is still pricing this as a binary "which architecture wins" story, but the more important near-term winner is the company that can monetize experimental demand into repeatable cloud usage and enterprise workflow integration. That structurally favors IONQ: bigger installed revenue base, better customer absorption, and more optionality from adjacent acquisitions that broaden use cases beyond a single compute niche. QBTS likely sees a valuation reset higher on the gate-model acquisition, but that is more of a thesis repair than a clear path to durable category leadership.

Second-order, the real bottleneck is not technical novelty but capex intensity and commercialization velocity. Both names are burning cash at a rate that forces them to keep raising the bar on growth; the market will tolerate deficits only if revenue inflects faster than dilution. That makes the next two quarters more important than the next two years: if enterprise and government bookings do not convert into larger, multi-year contracts, both stocks remain vulnerable to multiple compression even on good headline growth.

The consensus is likely underestimating how much the "winner" can be defined by infrastructure ownership rather than qubit purity. If IONQ’s vertical integration with foundry access works, it can lower iteration time, improve margins at scale, and reduce supply-chain fragility versus peers dependent on external fabrication ecosystems. QBTS, by contrast, could benefit from the fact that its repositioning makes it a more plausible M&A target or strategic partner, but that also means upside may be capped unless integration execution is clean and fast.

Key Decisions for Investors

• Long IONQ vs. short QBTS in a pair trade over the next 3-6 months; thesis is that relative revenue scale and broader platform optionality deserve a premium, while QBTS still needs proof that the acquisition translates into sustained commercial conversion.
• Use pullbacks to add IONQ on weakness, but only with a tight stop if quarterly growth decelerates materially; the stock likely retains momentum as long as revenue growth stays above the market’s implied 'hypergrowth' threshold.
• Buy a small tactical QBTS position only as a catalyst trade into integration milestones, not as a core hold; treat it as a 6-12 month re-rating story with high execution risk and lower conviction than IONQ.
• For event-driven exposure, consider IONQ call spreads into the next earnings print; upside is asymmetric if management shows backlog-to-revenue conversion, but premium should be capped because any delay in commercialization can hit the multiple quickly.
• Avoid naked long exposure in both names at once; if quantum sentiment weakens, these can de-rate together on dilution fears, so prefer relative-value or options structures over outright beta.